Select Page

re query

Home Forums Infexion Connexion re query

 | Click to Receive Email Notifications of Posts
Viewing 2 posts - 1 through 2 (of 2 total)
  • Author
    Posts
  • #74210
    Lawson, Chris
    Participant

    Author:
    Lawson, Chris

    Email:
    LawsonC@RAMSAYHEALTH.COM.AU

    Organisation:

    State:

    Hi,

    Can I raise this with the infection control group for investigation – some staff have given some information as to possible health risks for patients (cytotoxic risks) from the processing of pre-printed labels which get processed with the reusable instruments.
    Has anyone else heard of this? I have found one article in the research which talks about the potential. (See attachment). The easiest solution would be to simply process the labels separately and remove any possible risk to the patients or instrumentation.
    Is this something we can or should consider?

    Regards,
    Christine Lawson
    Nursing Admin
    [cid:image001.png@01D37421.726E7260]

    [http://www.ramsayhealth.com/~/media/Images/email/email-RHC-logo.jpg]

    Caboolture Private Hospital
    Quality & Risk Manager, Infection Control Coordinator, Education Coordinator
    Phone:

    07 5495 9418

    Email:

    LawsonC@ramsayhealth.com.au

    Web:

    http://www.ramsayhealth.com

    Address:

    Caboolture Private Hospital McKean Street, CABOOLTURE QLD 4510

    This e-mail message and any accompanying files may contain
    information that is confidential and subject to privilege. If you
    are not the intended recipient, and have received the e-mail
    in error, you are notified that any use, dissemination,
    distribution, forwarding, printing or copying of the message
    and any attached files is strictly prohibited. If you have
    received this e-mail message in error please immediately
    advise the sender by return e-mail, or telephone 1800 243 903.
    You must destroy the original transmission and its contents.
    Any views expressed within this communication are those of
    the individual sender, except where the sender specifically
    states them to be the views of Ramsay Health Care.
    This communication should not be copied or disseminated
    without permission.

    MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.

    The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.

    Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.

    Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au

    To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.

    You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@aicalist.org.au

    #74213
    Anonymous
    Inactive

    Author:
    Anonymous

    Organisation:

    State:

    Hi Christine,

    This issue reared its ugly head about 10 years ago in the sterilising
    services sector. Basically there were concerns about latex being in the
    printer toner used for printing / photocopying count sheets. There were also
    issues with ink transference onto instruments if the printed side came into
    contact with an instrument during the sterilisation process.

    It ended up as a storm in a teacup. As you can see by the conclusion in that
    paper, it was demonstrated that the printer ink was not cytotoxic.

    I’ve quickly scanned the most recently published international standards and
    guidance documents and not one of them raises any issues at all or discusses
    cytotoxicity risk of inks used for instrument count sheets, pre-printed
    labels that are attached to the packs and / or pens used to write on labels.
    There is however a reference to ensuring that the inks are non-toxic.

    You will also likely find that commercially supplied products for labelling
    have undergone some form of biocompatibility testing before being released
    for use as medical device labelling products.

    I’d be curious to see the information that the staff have been given, in
    particular the source of this information and the claims upon which this
    information has been based.

    Kind Regards

    Terry McAuley

    Sterilisation & Infection Prevention and Control Consultant

    STEAM Consulting Pty Ltd ACN 604 439 698

    E: terry@steamconsulting.com.au

    W: http://www.steamconsulting.com.au

    A: PO BOX 779

    Endeavour Hills

    VIC Australia 3802

    CONFIDENTIAL COMMUNICATION: The information contained in this message may
    contain confidential information intended only for the use of the individual
    or entity named above. If the reader of this message is not the intended
    recipient, you are hereby notified that any dissemination, distribution or
    duplication of this transmission is strictly prohibited. If you have
    received this communication in error, please notify us by telephone or email
    immediately and return the original message to us or destroy all printed and
    electronic copies. Nothing in this transmission constitutes an agreement of
    any kind unless otherwise expressly indicated.

    Of Lawson, Christine

    Hi,

    Can I raise this with the infection control group for investigation – some
    staff have given some information as to possible health risks for patients
    (cytotoxic risks) from the processing of pre-printed labels which get
    processed with the reusable instruments.
    Has anyone else heard of this? I have found one article in the research
    which talks about the potential. (See attachment). The easiest solution
    would be to simply process the labels separately and remove any possible
    risk to the patients or instrumentation.

    Is this something we can or should consider?

    Regards,

    Christine Lawson
    Nursing Admin

    Caboolture Private Hospital
    Quality & Risk Manager, Infection Control Coordinator, Education Coordinator

    Phone:

    07 5495 9418

    Email:

    LawsonC@ramsayhealth.com.au

    Web:

    http://www.ramsayhealth.com

    Address:

    Caboolture Private Hospital McKean Street, CABOOLTURE QLD 4510

    This e-mail message and any accompanying files may contain
    information that is confidential and subject to privilege. If you
    are not the intended recipient, and have received the e-mail
    in error, you are notified that any use, dissemination,
    distribution, forwarding, printing or copying of the message
    and any attached files is strictly prohibited. If you have
    received this e-mail message in error please immediately
    advise the sender by return e-mail, or telephone 1800 243 903.
    You must destroy the original transmission and its contents.
    Any views expressed within this communication are those of
    the individual sender, except where the sender specifically
    states them to be the views of Ramsay Health Care.
    This communication should not be copied or disseminated
    without permission.

    MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO
    NOT REPRESENT THE OPINION OF ACIPC.

    The use of trade/product/commercial brand names through the list is
    discouraged by ACIPC. If you wish to discuss specific reference to products
    or services by brand or commercial names, please do this outside the list.

    Archive of all messages are available at http://aicalist.org.au/archives
    registration and login required.

    Replies to this message will be directed back to the list. To create a new
    message send an email to aicalist@aicalist.org.au

    To send a message to the list administrator send an email to
    aicalist-request@aicalist.org.au .

    You can unsubscribe from this list be sending ‘signoff aicalist’ (without
    the quotes) to listserv@aicalist.org.au

    MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.

    The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.

    Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.

    Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au

    To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.

    You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@aicalist.org.au

Viewing 2 posts - 1 through 2 (of 2 total)
  • The forum ‘Infexion Connexion’ is closed to new topics and replies.